Yosuke Ota

Akashi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Definitive IMRT alone with reduced prophylactic nodal irradiation for Early-Stage Oropharyngeal Cancer: JCOG1208.

Definitive IMRT alone with reduced prophylactic nodal irradiation for Early-Stage Oropharyngeal Cancer: JCOG1208.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 28, 2026

The effectiveness of the QUAD shot regimen for advanced head and neck squamous cell carcinoma: a multicenter prospective observational study (JROSG 18-2).

The effectiveness of the QUAD shot regimen for advanced head and neck squamous cell carcinoma: a multicenter prospective observational study (JROSG 18-2).

Journal: Practical radiation oncology

Published: January 15, 2026

Effectiveness of the QUAD Shot Regimen for Advanced Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Observational Study (Japanese Radiation Oncology Study Group 18-2).

Effectiveness of the QUAD Shot Regimen for Advanced Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Observational Study (Japanese Radiation Oncology Study Group 18-2).

Journal: Practical radiation oncology

Published: January 15, 2026

Examination of the potential clinical application of 5DEX-0509R, the tumor macrophage-targeting nanomedicine.

Examination of the potential clinical application of 5DEX-0509R, the tumor macrophage-targeting nanomedicine.

Journal: Cytokine

Published: November 08, 2024

Targeting Tumor-Associated Macrophages with the Immune-Activating Nanomedicine for Achieving Strong Antitumor Activity with Rapid Clearance from the Body.

Targeting Tumor-Associated Macrophages with the Immune-Activating Nanomedicine for Achieving Strong Antitumor Activity with Rapid Clearance from the Body.

Journal: ACS nano

Published: August 14, 2024

Prognostic Factors of Oligometastasis After Stereotactic Body Radiotherapy: The Real-World Utility of the European Society for Radiotherapy and Oncology/European Organisation for Research and Treatment of Cancer Classification.

Prognostic Factors of Oligometastasis After Stereotactic Body Radiotherapy: The Real-World Utility of the European Society for Radiotherapy and Oncology/European Organisation for Research and Treatment of Cancer Classification.

Journal: Cureus

Published: May 19, 2024

DSP-0509, a TLR7 agonist, exerted synergistic anti-tumor immunity combined with various immune therapies through modulating diverse immune cells in cancer microenvironment.

DSP-0509, a TLR7 agonist, exerted synergistic anti-tumor immunity combined with various immune therapies through modulating diverse immune cells in cancer microenvironment.

Journal: Frontiers in oncology

Published: April 01, 2024

Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells.

Design, synthesis, and biological evaluation of phenylcyclopropylamine-entinostat conjugates that selectively target cancer cells.

Journal: Bioorganic & medicinal chemistry

Published: December 23, 2023

Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD-1 antibody for BRAF-mutated melanoma.

Tumor eradication by triplet therapy with BRAF inhibitor, TLR 7 agonist, and PD-1 antibody for BRAF-mutated melanoma.

Journal: Cancer science

Published: December 19, 2023

Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation.

Discovery of Selective Histone Deacetylase 1 and 2 Inhibitors: Screening of a Focused Library Constructed by Click Chemistry, Kinetic Binding Analysis, and Biological Evaluation.

Journal: Journal of medicinal chemistry

Published: October 17, 2023

A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer.

A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer.

Journal: International journal of clinical oncology

Published: July 30, 2023

TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation.

TLR7 agonist, DSP-0509, with radiation combination therapy enhances anti-tumor activity and modulates T cell dependent immune activation.

Journal: BMC immunology

Published: June 09, 2023

Showing 1-12 of 50

Last Updated: 09/26/2026